Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc) |
| BNF code | 1404000ATBHAAAG |
| Virtual Medicinal Product | Generic Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials |
| Name | Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials |
| Abbreviated name | Spikevax COVID-19 mRNA Vaccine 0.5ml inj multidose vials |
| Date of name applicability | 15 Sep 2021 |
| Previous name | COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5ml dose dispersion for injection multidose vials |
| Supplier | Moderna, Inc |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc) 100 dose 10 x 10 dose vials | |
| Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc) 10 dose | |
dm+d data retrieved from TRUD: release NHSBSA_6.3.0_20240624000001, imported on 24th June 2024 at 05:06:11.